参考文献/References:
[1]WOOLF C J, MANNION R J. Neuropathic pain: aetiology, symptoms, mechanisms, and management[J]. Lancet, 1999, 353(9168): 1959-1964. DOI:10.1016/S0140-6736(99)01307-0.
[2]ARAI M, GENDA Y, ISHIKAWA M, et al. The miRNA and mRNA changes in rat hippocampi after chronic constriction injury[J]. Pain Med, 2013, 14(5): 720-729. DOI:10.1111/pme.12066.
[3]LPEZGONZLEZ M J, LANDRY M, FAVEREAUX A. MicroRNA and chronic pain: From mechanisms to therapeutic potential[J]. Pharmacol Ther, 2017, 180: 1-15. DOI:10.1016/j.pharmthera.2017.06.001.
[4]VON SCHACK D, AGOSTINO M J, MURRAY B S, et al. Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain[J]. PLoS ONE, 2011, 6(3): e17670. DOI:10.1371/journal.pone.0017670.
[5]LIU M, WANG Z, YANG S, et al. TNFα is a novel target of miR19a[J]. Int J Oncol, 2011, 38(4): 1013-1022. DOI:10.3892/ijo.2011.924.
[6]BENNETT G J, XIE Y K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man[J]. Pain, 1988, 33(1): 87-107. DOI:10.1016/0304-3959(88)90209-6.
[7]CHEN H, LI X, LIU S, et al. MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis[J]. Sci Rep, 2017, 7(1): 12089. DOI:10.1038/s41598-017-12167-z.
[8]SAKAI A, SAITOW F, MARUYAMA M, et al. MicroRNA cluster miR-17-92 regulates multiple functionally related voltage-gated potassium channels in chronic neuropathic pain[J]. Nat Commun, 2017, 8: 16079. DOI:10.1038/ncomms16079.
[9]LIU S, MI W L, LI Q, et al. Spinal IL-33/ST2 signaling contributes to neuropathic pain via neuronal CaMKII-CREB and astroglial JAK2-STAT3 cascades in mice[J]. Anesthesiology, 2015, 123(5): 1154-1169. DOI:10.1097/ALN.0000000000000850.
[10]WANG Z F, LI Q, LIU S B, et al. Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in rats[J]. Neuroscience, 2014, 273: 65-78. DOI:10.1016/j.neuroscience.2014.04.052.
[11]DOMINGUEZ E, MAUBORGNE A, MALLET J, et al. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury[J]. J Neurosci, 2010, 30(16): 5754-5766. DOI:10.1523/JNEUROSCI.500709.2010.
[12]DUBOVY P, KLUS-KOV- I, SV-ZENSK- I, et al. Satellite glial cells express IL-6 and corresponding signaltransducing receptors in the dorsal root ganglia of rat neuropathic pain model[J]. Neuron Glia Biol, 2010, 6(1): 73-83. DOI:10.1017/S1740925X10000074.
[13]LI D, YAN Y, YU L, et al. Procaine attenuates pain behaviors of neuropathic pain model rats possibly via inhibiting JAK2/STAT3[J]. Biomol Ther (Seoul), 2016, 24(5): 489-494. DOI:10.4062/biomolther.2016.006.
[14]LIU S, LI Q, ZHANG M T, et al. Curcumin ameliorates neuropathic pain by downregulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling[J]. Sci Rep, 2016, 6: 28956. DOI:10.1038/srep28956.
[15]HORIGUCHI A, ASANO T, KURODA K, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma[J]. Br J Cancer, 2010, 102(11): 1592-1599. DOI:10.1038/sj.bjc.6605691.
[16]BABON J J, KERSHAW N J, Murphy J M, et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity[J]. Immunity, 2012, 36(2): 239-250. DOI:10.1016/j.immuni.2011.12.015.
[17]BABON J J, VARGHESE L N, NICOLA N A. Inhibition of IL-6 family cytokines by SOCS3[J]. Semin Immunol, 2014, 26(1): 13-19. DOI:10.1016/j.smim.2013.12.004.
[18]LATR-MOLI-RE A, MAUBORGNE A, MASSON J, et al. Differential implication of proinflammatory cytokine interleukin6 in the development of cephalic versus extracephalic neuropathic pain in rats[J]. J Neurosci, 2008, 28(34): 8489-8501. DOI:10.1523/JNEUROSCI.255208.2008.
[19]BRUMANN M, MATZ M, KUSMENKOV T, et al. Impact of STAT/SOCS mRNA expression levels after major injury[J]. Mediators Inflamm, 2014, 2014: 749175. DOI:10.1155/2014/749175.
[20]XUE Z J, SHEN L, WANG Z Y, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats[J]. Brain Res, 2014, 1583: 79-88. DOI:10.1016/j.brainres.2014.07.015.
[21]BAKER B J, AKHTAR L N, BENVENISTE E N. SOCS1 and SOCS3 in the control of CNS immunity[J]. Trends Immunol, 2009, 30(8): 392-400. DOI:10.1016/j.it.2009.07.001.
[22]QIN H, YEH W I, DE SARNO P, et al. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation[J]. Proc Natl Acad Sci U S A, 2012, 109(13): 5004-5009. DOI:10.1073/pnas.1117218109.